Zoetis Inc. | Balance Sheet

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
610
882
1,154
727
1,564
1,701
Total Accounts Receivable
1,138
980
937
913
998
1,036
Inventories
1,293
1,289
1,467
1,502
1,427
1,391
Other Current Assets
316
314
272
248
228
271
Total Current Assets
3,357
3,465
3,830
3,390
4,217
4,399
Net Property, Plant & Equipment
1,295
1,318
1,307
1,381
1,435
1,658
Intangible Assets
1,785
1,703
2,645
2,709
2,779
4,565
Other Assets
57
66
48
70
72
81
Total Assets
6,558
6,607
7,913
7,649
8,586
10,777
ST Debt & Current Portion LT Debt
15
7
405
-
-
Accounts Payable
506
290
293
265
261
Income Tax Payable
55
37
74
71
60
Other Current Liabilities
839
752
1,009
781
773
Total Current Liabilities
1,415
1,086
1,781
1,117
1,094
Long-Term Debt
3,642
3,643
4,463
4,468
4,953
Provision for Risks & Charges
86
138
192
176
273
Deferred Taxes
258
222
181
145
297
Other Liabilities
131
126
122
145
100
Total Liabilities
5,596
5,270
6,822
6,150
6,800
Common Equity (Total)
940
1,311
1,068
1,487
1,770
Total Shareholders' Equity
940
1,311
1,068
1,487
1,770
Total Equity
962
1,337
1,091
1,499
1,786
Liabilities & Shareholders' Equity
6,558
6,607
7,913
7,649
8,586
Accumulated Minority Interest
22
26
23
12
16

About Zoetis

View Profile
Address
10 Sylvan Way
Parsippany New Jersey 07054
United States
Employees -
Website http://www.zoetis.com
Updated 07/08/2019
Zoetis, Inc. discovers, develops and manufactures a portfolio of animal health medicines and vaccines. Its products are complemented by diagnostic products, genetic tests, bio devices and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal.